Related Experiment Video
Updated: Aug 18, 2026
In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
Published on: February 17, 2012
Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence
Li Li1, Yingzi Luan, Xiping Li
1Department of Gynecologic Oncology, Cancer Institute and Hospital, Guangxi Medical University Medical Center, Nanning, Guangxi 530021, P.R. China. lili_temp@hotmail.com
Abstract:
Chemotherapy plays a major role in cancer management; however, acquired drug resistance remains a significant problem for ovarian cancer treatment. Chemoresistance is regulated by the coordinated expression of a set of genes. Thus, the identification of genes specifically modulated in the process provides an important step toward the discovery of underlying molecular mechanisms in drug resistance events. We recently developed five drug-resistant human ovarian carcinoma cell lines, including two cisplatin (cis) resistant cell lines, two carboplatin (car) resistant cell lines and one taxol (tax) resistant cell line. In this study, we investigated differential gene expression between these resistant cell lines and their parental cell lines by the fluorescence differential display-polymerase chain reaction (FDD-PCR) technique. We first screened and identified differentially expressed genes in the resistant ovarian cancer cell lines, and we then sequenced and analyzed these genes by bioinformatics software. A total of 33 fragments were displayed in the two resistant cell lines (S-cis and S-car) derived from the sensitive SKOV-3 cell line, and 36 fragments were displayed in the three resistant cell lines (A-cis, A-car and A-tax) derived from the sensitive A2780 cell line. After purification, cloning, sequencing, and homology analysis on the NCBI BLAST GenBank, 12 gene fragments were identified from the resistant S-cis and S-car cells, and 23 gene fragments were identified from the resistant A-cis, A-car and A-tax cells. Although a homolog search of the NIH GenBank revealed that most of the gene fragments were not significantly associated with the known drug resistance-related genes, our study conclusively demonstrates that FDD-PCR is a useful tool for analyzing the differential gene expression between resistant and sensitive tumor cells and for identifying novel chemoresistance-associated genes and potential biological markers or genetic markers of drug resistance.
Insights
Researchers identified novel genes associated with ovarian cancer drug resistance using fluorescence differential display-PCR. This technique helps uncover molecular mechanisms and potential biomarkers for chemoresistance, improving cancer treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Acquired chemoresistance is a major challenge in ovarian cancer treatment.
- Gene expression modulation is key to understanding chemoresistance mechanisms.
- Developing drug-resistant cell lines is crucial for studying resistance.
Purpose of the Study:
- To identify differentially expressed genes in ovarian cancer cell lines resistant to cisplatin, carboplatin, and taxol.
- To explore the utility of fluorescence differential display-polymerase chain reaction (FDD-PCR) for identifying novel chemoresistance-associated genes.
- To find potential biological or genetic markers for drug resistance in ovarian cancer.
Main Methods:
- Development of five drug-resistant human ovarian carcinoma cell lines (cisplatin, carboplatin, taxol resistant).
- Application of fluorescence differential display-polymerase chain reaction (FDD-PCR) to compare gene expression between resistant and parental cell lines.
- Bioinformatic analysis including gene sequencing, homology search (NCBI BLAST GenBank).
Main Results:
- FDD-PCR identified 33 differentially expressed gene fragments in SKOV-3 derived resistant cells and 36 in A2780 derived resistant cells.
- 12 gene fragments were identified from SKOV-3 derived resistant cells and 23 from A2780 derived resistant cells after sequencing and analysis.
- Most identified gene fragments lacked significant association with previously known drug resistance genes, suggesting novel discoveries.
Conclusions:
- Fluorescence differential display-polymerase chain reaction (FDD-PCR) is an effective tool for analyzing differential gene expression in chemoresistant tumor cells.
- The study successfully identified novel candidate genes associated with ovarian cancer drug resistance.
- These findings provide a foundation for discovering new biomarkers and understanding molecular mechanisms of chemoresistance.
